Literature DB >> 15823284

Low adipocyte IRS-1 protein expression is associated with an increased arterial stiffness in non-diabetic males.

Madeléne Sandqvist1, Gunnar Nyberg, Ann Hammarstedt, Natalia Klintland, Silvia Gogg, Kenneth Caidahl, Bo Ahrén, Ulf Smith, Per-Anders Jansson.   

Abstract

OBJECTIVE: Low adipocyte IRS-1 protein expression is a biomarker for insulin resistance and early atherosclerosis. However, whether IRS-1 protein expression is related to systemic arterial stiffness, is unknown. METHODS AND
RESULTS: Ten non-diabetic male subjects with low adipocyte IRS-1 protein expression (LIRS) were matched with 10 non-diabetic males with normal IRS-1 protein expression (NIRS). Augmentation index (AIx) and time for reflection of pulse wave (Tr) were studied with pulse wave analysis, both in the fasting state and during a euglycemic hyperinsulinemic clamp. The LIRS-group showed an increased fasting insulin concentration (fP-insulin 71+/-4 pmol/L versus 58+/-5 pmol/L; p=0.02 (mean+/-S.E.)), whereas glucose disposal rate during the clamp (8.7+/-0.8 mg/kg LBM/min versus 10.3+/-1.3 mg/kg LBM/min; n.s.) did not differ significantly. Blood pressure, lipid parameters, adiponectin, endothelin-1 and CRP concentrations were similar. However, in the basal state, AIx was increased (129+/-4% versus 116+/-2%; p<0.02) and Tr was decreased (150+/-3 ms versus 171+/-5 ms; p<0.01), suggesting stiffer vessels in the LIRS-group. The LIRS-group exhibited an attenuated AIx response to hyperinsulinemia compared to the NIRS-group.
CONCLUSIONS: The data suggest that non-obese non-diabetic men with a low adipocyte IRS-1 protein expression have an increased systemic arterial stiffness.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15823284     DOI: 10.1016/j.atherosclerosis.2004.11.006

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  4 in total

1.  Regional variations in the relationship between arterial stiffness and adipocyte volume or number in obese subjects.

Authors:  P Arner; J Bäckdahl; P Hemmingsson; P Stenvinkel; D Eriksson-Hogling; E Näslund; A Thorell; D P Andersson; K Caidahl; M Rydén
Journal:  Int J Obes (Lond)       Date:  2014-07-08       Impact factor: 5.095

Review 2.  Endothelial dysfunction, inflammation, and apoptosis in diabetes mellitus.

Authors:  Inge A M van den Oever; Hennie G Raterman; Mike T Nurmohamed; Suat Simsek
Journal:  Mediators Inflamm       Date:  2010-06-15       Impact factor: 4.711

Review 3.  Cardiovascular mortality in psoriasis and psoriatic arthritis: epidemiology, pathomechanisms, therapeutic implications, and perspectives.

Authors:  Wolf-Henning Boehncke; Sandra Boehncke
Journal:  Curr Rheumatol Rep       Date:  2012-08       Impact factor: 4.592

4.  Increased MAPK activation and impaired insulin signaling in subcutaneous microvascular endothelial cells in type 2 diabetes: the role of endothelin-1.

Authors:  Silvia Gogg; Ulf Smith; Per-Anders Jansson
Journal:  Diabetes       Date:  2009-07-06       Impact factor: 9.461

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.